MYCIO Wealth Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MYCIO Wealth Partners's XBI Position: Q1 2020 in Review
MYCIO Wealth Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2020, closing a stake of 6,779 shares — an estimated $645K sold.
MYCIO Wealth Partners first reported a position in XBI in Q4 2014 and held it in 14 quarters. The position peaked at $645K in Q4 2019. 458 funds tracked by Wall St. Rank hold XBI as of Q1 2020.
- MYCIO Wealth Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2020 after selling out during the quarter.
- MYCIO Wealth Partners sold 6,779 State Street SPDR S&P Biotech ETF shares in Q1 2020, an estimated $645K.
- MYCIO Wealth Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and held it in 14 quarters.
- MYCIO Wealth Partners's State Street SPDR S&P Biotech ETF position peaked at $645K in Q4 2019.
- 458 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2020.
Based on MYCIO Wealth Partners's 13F filing for Q1 2020, filed 14 May 2020.